Physician
Compre Hensive Primary Care Medical Associates, INC
Compre Hensive Primary Care Medical Associates, INC was paid $16.11M by Medicaid between Jan 2018 and Nov 2024, across 44 billing codes. Its largest line is S9083, Global fee urgent care centers — 65% of everything it billed.
33Billing provider infoCOMPRE HENSIVE PRIMARY CARE MEDICAL ASSOCIATES, INC
FONTANA, CA 92336
FONTANA, CA 92336
33aNPI1982786620assigned 10/20/2006
33bProvider typeFamily Medicine Physician
28Total paid$16.11M
24GClaims254,654
24DCodes billed44
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#29 of 2,511
Median peer was paid$13K
This provider vs. median1,254×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,638 | $3.41M | |
| 2019 | 38,195 | $3.62M | |
| 2020 | 33,018 | $2.70M | |
| 2021 | 31,252 | $1.83M | |
| 2022 | 38,843 | $1.49M | |
| 2023 | 41,001 | $1.51M | |
| 2024incomplete | 36,707 | $1.55M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S9083 | Global fee urgent care centers | 65% | 105,468 | 96,060 | $10.46M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 54,753 | 52,349 | $2.10M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 10% | 28,725 | 28,691 | $1.67M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.5% | 28,185 | 27,091 | $723K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.4% | 9,045 | 3,841 | $390K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.7% | 4,736 | 4,649 | $274K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 6,663 | 6,278 | $128K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,601 | 2,466 | $99K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 1,138 | 1,137 | $68K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,737 | 798 | $54K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,305 | 711 | $48K |
| 99205 | Prolong outpt/office vis | <1% | 323 | 323 | $27K |
32 more codes
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,026 | $23K |
| 0001A | <1% | 150 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 930 | $5K |
| 99385 | <1% | 47 | $5K | |
| 0002A | <1% | 107 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 43 | $3K |
| 81003 | <1% | 1,369 | $2K | |
| 97750 | <1% | 58 | $1K | |
| 92552 | <1% | 46 | $1K | |
| 81025 | <1% | 182 | $1K | |
| 97161 | <1% | 29 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 29 | $797.24 |
| 99000 | <1% | 718 | $760.97 | |
| 82962 | <1% | 609 | $491.34 | |
| 90674 | <1% | 19 | $473.10 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 92 | $428.51 |
| 90686 | <1% | 27 | $264.90 | |
| 86328 | <1% | 41 | $180.92 | |
| 96127 | <1% | 16 | $84.56 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 169 | $11.52 |
| 81002 | <1% | 17 | $4.26 | |
| 81000 | <1% | 219 | $2.55 | |
| 3078F | 0% | 142 | $0.00 | |
| A4617 | Mouth piece | 0% | 135 | $0.00 |
| 3077F | 0% | 41 | $0.00 | |
| 90714 | 0% | 17 | $0.00 | |
| 3074F | 0% | 336 | $0.00 | |
| 3008F | 0% | 30 | $0.00 | |
| 3079F | 0% | 59 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 107 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 87 | $0.00 |
| 3075F | 0% | 78 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBEMBI, ATUL (CEO)
| Provider | Location | Paid |
|---|---|---|
| West Point Medical Group, INC | San Bernardino, CA | $1.31M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.